Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
Autor: | Ciuleanu, Tudor-Eliade, Ahmed, Samreen, Kim, Joo-Hang, Mezger, Jörg, Park, Keunchil, Thomas, Michael, Chen, Jihong, Poondru, Srinivasu, VanTornout, Jan M, Whitcomb, Debbie, Blackhall, Fiona, Mezger, Jörg |
---|---|
Předmět: |
PLACEBOS
PLATINUM compounds ANTINEOPLASTIC agents CELL receptors DRUG therapy COMPARATIVE studies HETEROCYCLIC compounds LUNG cancer IMIDAZOLES LUNG tumors RESEARCH methodology MEDICAL cooperation RESEARCH STATISTICAL sampling EVALUATION research RANDOMIZED controlled trials KAPLAN-Meier estimator THERAPEUTICS |
Zdroj: | British Journal of Cancer; 9/5/2017, Vol. 117 Issue 6, p757-766, 10p, 5 Charts, 1 Map |
Abstrakt: | |
Databáze: | Complementary Index |
Externí odkaz: |